Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Fibromatosis, Aggressive
  • Piperazines
  • Pyrimidines

abstract

  • Imatinib may have a role in the management of unresectable or difficult to resect desmoid tumors.

publication date

  • October 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-10-1177

PubMed ID

  • 20724445

Additional Document Info

start page

  • 4884

end page

  • 91

volume

  • 16

number

  • 19